These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7022473)

  • 1. Erythrocyte calcium abnormalities in sickle cell disease.
    Hebbel RP; Steinberg MH; Eaton JW
    Prog Clin Biol Res; 1981; 51():321-32. PubMed ID: 7022473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease.
    Hebbel RP; Yamada O; Moldow CF; Jacob HS; White JG; Eaton JW
    J Clin Invest; 1980 Jan; 65(1):154-60. PubMed ID: 7350195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte/endothelial interactions in the pathogenesis of sickle-cell disease: a "real logical" assessment.
    Hebbel RP; Eaton JW; Steinberg MH; White JG
    Blood Cells; 1982; 8(1):163-73. PubMed ID: 7115974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversibly sickled erythrocytes: a consequence of the heterogeneous distribution of hemoglobin types in sickle-cell anemia.
    Bertles JF; Milner PF
    J Clin Invest; 1968 Aug; 47(8):1731-41. PubMed ID: 5666109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte membrane abnormalities in sickle cell disease.
    Williamson P; Puchulu E; Westerman M; Schlegel RA
    Biotechnol Appl Biochem; 1990 Oct; 12(5):523-8. PubMed ID: 2288707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Established and experimental treatments for sickle cell disease.
    De Franceschi L; Corrocher R
    Haematologica; 2004 Mar; 89(3):348-56. PubMed ID: 15020275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity.
    Hebbel RP; Boogaerts MA; Eaton JW; Steinberg MH
    N Engl J Med; 1980 May; 302(18):992-5. PubMed ID: 7366623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte/endothelial interactions and the vasocclusive severity of sickle cell disease.
    Hebbel RP; Eaton JW; Steinberg MH; White JG
    Prog Clin Biol Res; 1981; 55():145-62. PubMed ID: 7291188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium exchange and calcium-related effects in normal and sickle cell anemia erythrocytes.
    Cameron BF; Smariga P
    Prog Clin Biol Res; 1978; 20():105-22. PubMed ID: 148652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombosis and sickle cell disease.
    De Franceschi L; Cappellini MD; Olivieri O
    Semin Thromb Hemost; 2011 Apr; 37(3):226-36. PubMed ID: 21455857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence properties of sickle erythrocytes in dynamic flow systems.
    Burns ER; Wilkinson WH; Nagel RL
    J Lab Clin Med; 1985 Jun; 105(6):673-8. PubMed ID: 3998620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle erythrocytes adhere to endothelial cell monolayers (ECM's) exposed to flowing blood.
    Grabowski EF
    Prog Clin Biol Res; 1987; 240():167-79. PubMed ID: 3615485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denatured hemoglobin in sickle erythrocytes.
    Asakura T; Minakata K; Adachi K; Russell MO; Schwartz E
    J Clin Invest; 1977 Apr; 59(4):633-40. PubMed ID: 845254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The possible role of red blood cell microvesicles in atherosclerosis.
    Blum A
    Eur J Intern Med; 2009 Mar; 20(2):101-5. PubMed ID: 19327596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal vesiculation and calcium transport by 'one-step' inside-out vesicles from sickle cell anemia red cells. Comparisons with transport by intact cells.
    Bookchin RM; Raventos C; Lew VL
    Prog Clin Biol Res; 1981; 55():163-82. PubMed ID: 7291189
    [No Abstract]   [Full Text] [Related]  

  • 16. Extracorpuscular factors in the pathogenesis of sickle cell disease.
    Hebbel RP
    Am J Pediatr Hematol Oncol; 1982; 4(3):316-9. PubMed ID: 7149170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiologically based drug treatment of sickle cell disease.
    Steinberg MH
    Trends Pharmacol Sci; 2006 Apr; 27(4):204-10. PubMed ID: 16530854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte adhesion in sickle cell disease.
    Parise LV; Telen MJ
    Curr Hematol Rep; 2003 Mar; 2(2):102-8. PubMed ID: 12901140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyamines and globin binding in sickle cell disease.
    Natta CL; Motyczka AA; Kremzner LT
    Am J Pediatr Hematol Oncol; 1982; 4(1):73-6. PubMed ID: 7091579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-uniformity of intracellular polymer formation in sickle erythrocytes: possible correlation with severity of hemolytic anemia.
    Noguchi CT; Schechter AN
    Am J Pediatr Hematol Oncol; 1984; 6(1):46-50. PubMed ID: 6711762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.